Futura Medical (FUM:AIM) 16.5pLoss to date: 50%In October 2024, we highlighted sexual health specialist Futura Medical (FUM:AIM) as a great opportunity to get on board as it launched its ED (erectile dysfunction) product Eroxon into the US market through commercial partner Haleon (HLN).WHAT HAS HAPPENED SINCE WE SAID TO BUY?Although we acknowledged the extra risks of owning smaller, single...

Stocks in London were in the red on Monday during midday trading, as downbeat Chinese manufacturing data cast a cloud over equities.It is likely to be a quieter day, given that US markets will be closed today for the Labor Day holiday.The FTSE 100 index was down 13.03 points, or 0.2%, at 8,363.46. The FTSE 250 was down 61.15 points, or 0.3%, at 21,025.39, and the AIM All-Share was down 4.31...

London?s FTSE 100 ended higher on Tuesday, registering its first daily gain since hawkish words from Federal Reserve Chair Jerome Powell last week all but ensured there would be no March rate cut from the Federal Reserve.His words echoed around markets on Thursday, and there was a red-hot US jobs report on Friday, the final nail in the coffin for March rate cut hopes. Markets still digested...

Shares jump 8% after ground breaking US commercial deal with HaleonFirst over-the-counter erectile dysfunction treatment in the USUS is the world's largest ED market affecting 22 million menPharmaceutical company Futura Medical (FUM:AIM) hasn't wasted any time getting its innovative gel for erectile dysfunction MED3000 into the US market after revealing a 'ground-breaking' commercial agreement...

For a small company with only 12 employees including directors, pharmaceutical company Futura Medical (FUM:AIM) punches way above its weight. It has created the first significant innovation in the erectile dysfunction market in over 20 years with its proprietary transdermal DermaSys technology.Having secured UK and European regulatory approval for its fast-acting erectile dysfunction gel the...

Major UK shares struggled for momentum on Tuesday as banks and airlines countered gains in miners, although solid earnings and easing fears about early tapering of central bank support kept the blue-chip index on course for its best month since April.At 9am, the benchmark FTSE 100 was by and large flat, inching less than 10 points lower to 7,139.43. Miners gained 1.4% on higher metal prices,...

London shares ended Monday moderately higher despite volatility earlier in the day due to a vaccine spat between the EU and UK, pressure on the travel sector and a currency crisis in Turkey.The UK's benchmark FTSE 100 index closed 0.26% higher to 6,726.10, while midcap FTSE 250 index also ended in positive territory with a 0.17% gain to 21,455.89.Investors had started the day's trading in a...

London shares have turned positive after up and down morning trading on Monday as pressure on the travel sector, a currency crisis in Turkey and a vaccine spat between the EU and UK led to volatile trading.By lunchtime, the UK's benchmark FTSE 100 index had reversed earlier losses to trade 0.13% higher to 6,717.69, while midcap FTSE 250 index also moved into positive territory with a 0.48%...

The UK's major stocks fell on Monday with investors worried about the stability of recovery as the EU's threat to withhold vaccine exports to the UK added to the tetchy mood on the London market.The benchmark FTSE 100 declined 0.36% to 6,684.85 in early trading as energy and mining stocks dragged as oil and metals prices slipped over fears of slowing demand. Investors also continue to fret...

Advice-led wealth manager AFH Financial (AFHP:AIM) reported strong full-year growth in revenues of 47% to £74.3m and earnings per share up 45% to 32.8p for the period ended 31 October 2019.The shares added 3.7% to 399p and are up 42% over the last three-months.Chief executive Alan Hudson said, 'trading remains strong and in line with the board's expectations and the current levels of activity...

UK stocks started the week lower after Asian markets sank as protests in Hong Kong and ongoing uncertainty over a US-China trade deal cast a shadow over trading. China's Shanghai Composite index fell 0.5% while Hong Kong's Hang Seng index fell 0.6%.At 8.30am the FTSE 100 was down by 0.5% to 7,319 with banks, industrials, metals, mining and oil equipment holding the index back while the mid-cap...

AIM-quoted AFH Financial (AFHP:AIM) has grown rapidly in the last few years to become one of the UK's leading financial planning led-wealth managers with more than £5bn of funds under management (FUM).Thanks to strong organic growth and the potential to add more customers through well-timed acquisitions, AFH could easily double its assets and profits in the near future.EXPERIENCE COUNTSThe...

Investors are overlooking commercial progress at pharmaceutical group Futura Medical (FUM:AIM) as the market concentrates on still piddling revenue and huge losses. The share price fell 3% to 55p as the AIM tiddler reported sales of just £170,362 in the year to 31 December 2016. That represents a five-fold jump from the £29,476 posted in 2015 and came in above the £110,000 expectations of...

Healthcare firm Futura Medical's (FUM) erectile dysfunction treatment MED2002 is believed to have a market potential of $1bn, according to leading market researcher Ipsos.MED2002 is an over-the-counter topical gel, which could be developed into a stronger version, available only through prescription.FAST-ACTING TREATMENTThe treatment's onset of action within five minutes means it could be sold...

Blue chip shares in London open flat at 6,704 as winners and losers from lower oil prices broadly offset each other.Index giant Royal Dutch Shell (RDSB) is under pressure as West Texas Intermediate crude prices dip 1.4% to $45.63 (£34.30), while British Airlines owner International Consolidated Airlines (IAG), a key beneficiary of lower oil prices, is the biggest gainer.Sports retailer JD...

A small British company has moved a step closer to being given the green light to challenge Viagra for supremacy of the impotency market.Guildford-based micro-cap Futura Medical (FUM:AIM) is poised to sell a gel into the $5 billion erectile dysfunction market after trials proved that MED2002 is safe and that it works.Management also point to it working faster than the pills currently...

After gains on Wall Street and falls in Asia overnight the FTSE 100 is flat this morning at 6,286.06.Trading platform CMC Markets (CMCX) sinks 11.4% to 245.5p as it warns first half net operating income will be lower year-on-year as it says low levels of market volatility provide fewer trading opportunities for its clients.Traditional stockbroker Hargreaves Lansdown (HL.) is also under...

The London stock market opens modestly lower with a swathe of negative corporate announcements weighing on already fragile confidence. EU Referendum concerns continue while investors are waiting on a key speech from US central bank chairwoman Janet Yellen later today.The FTSE 100 index drifts around 10 points lower to 6,190, while midcap FTSE 250 stocks are also in decline.In corporate news,...

News that Futura Medical (FUM:AIM) is to sell its erection-maintaining condom in India, sends the shares 8.3% higher to 19.5p.The drugs-through-the-skin delivery specialist, which also makes pain relief and erectile dysfunction gels, has signed a deal that will see its CSD500 condom made and then sold in India by local outfit TTK Protective Devices.The condom, which works thanks to a special...

Traders are snapping up haven-style assets as data released overnight increased uncertainty over the health of economies in China and Japan.Gold miners and pharmaceutical stocks lead the way in the FTSE 100, which trades 0.3% lower at 6,099, as markets around the world start the week in the red.Overnight, Japan's Business Survey Index slipped to minus 11.1 in April-June, down from minus 7.9 in...